ScreenerHero

NBP NovaBridge Biosciences

NAS · US · Healthcare · Biotechnology · novabridge.com
1.370USD-2.14%Mkt Cap: 158.92M $P/E: —

NovaBridge Biosciences, a biotechnology company, engages in the research and development of immuno-oncology agents for the treatment of cancer in the United States. The company operates through two segments, Oncology and…

Industry Peers

Biotechnology
Screen all
VRTX
Vertex Pharmaceuticals Incorporated
$128.08BUSDP/E 29.4
MRNA
Moderna, Inc.
$78.44BUSD
REGN
Regeneron Pharmaceuticals, Inc.
$76.40BUSDP/E 18.4
ARGX
argenx SE
$57.03BUSDP/E 37.3
ARGX
argenx SE
$58.08BUSDP/E 35.4
UCB
UCB SA
$42.24BUSDP/E 18.0
RVMD
Revolution Medicines, Inc.
$43.05BUSD
ONC
BeOne Medicines AG
$41.41BUSDP/E 65.1
RPRX
Royalty Pharma plc
$32.80BUSDP/E 30.2
ALNY
Alnylam Pharmaceuticals, Inc.
$30.03BUSDP/E 37.8
ROIV
Roivant Sciences Ltd.
$25.10BUSD
BNTX
BioNTech SE
$23.93BUSD
INCY
Incyte Corporation
$22.99BUSDP/E 14.5
GMAB
Genmab A/S
$22.27BUSDP/E 30.7
GMAB
Genmab A/S
$22.54BUSDP/E 28.9
INSM
Insmed Incorporated
$22.22BUSD
ASND
Ascendis Pharma A/S
$15.03BUSDP/E 17.5
JAZZ
Jazz Pharmaceuticals plc
$15.01BUSDP/E 15.8
EXEL
Exelixis, Inc.
$14.48BUSDP/E 18.4
SMMT
Summit Therapeutics Inc.
$14.32BUSD

Key Statistics

Company
Market Cap158.92M USD
Enterprise Value-23.99M USD
Revenue (TTM)—
Gross Profit—
Net Income (TTM)-46.27M USD
Revenue/Share—
Last Price1.370 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees30
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-1.32
PEG—
EV/EBITDA0.20
EV/Revenue—
P/S—
P/B0.81
EPS (TTM)-0.69
EPS (Forward)-1.06
52W Range
1.3151% of range6.790
52W High6.790 USD
52W Low1.315 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-20.03%
ROA-17.76%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-20.60M USD
CapEx (TTM)7.00K USD
FCF Margin—
FCF Yield-29.94%
Net Debt-186.39M USD
Net Debt/EBITDA1.52
Balance Sheet
Debt/Equity0.01
Current Ratio7.64
Quick Ratio7.58
Book Value/Sh1.73 USD
Cash/Share1.65 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)9.000 USD
Upside (mean)+556.9%
Target Range9.000 USD – 9.000 USD
# Analysts2
Ownership
Shares Out.116.00M
Float64.45M
Insiders14.28%
Institutions34.23%
Short Interest
Short Ratio14.4d
Short % Float7.16%
Short % Out.3.23%
Shares Short3.75M
Short (prev mo.)4.58M
Technical
SMA 501.692 (-19.0%)
SMA 2002.446 (-44.0%)
Beta1.60
S&P 52W Chg15.78%
Avg Vol (30d)514.33K
Avg Vol (10d)1.02M
Technical Indicators
RSI (14)31.3
MACD-0.1070
MACD Signal-0.1021
MACD Hist.-0.0049
BB Upper1.784 USD
BB Middle1.502 USD
BB Lower1.220 USD
BB Width37.59%
ATR (14)0.0720 USD
Vol Ratio (20d)0.57x